Author
1 MIN READ
Cole Lannum, senior vice president of investor strategy at Covidien spin-off Mallinckrodt, discusses the challenges brought on by the changing environment for the specialty pharmaceuticals sector. The multiple awards winner gives his top tip for IROs: treat investors like customers, not adversaries.
In partnership with WHEN 8.00 am PT / 11.00 am ET / 4.00 pm BST / 5.00 pm CET DURATION 45 minutes About the event Amid constant tariff news, geopolitical upheaval and other developments stemming from the new US administration, IR teams have their work cut out as they prepare…
Stay informed on critical issues affecting IR teams, gain expert analysis of market trends, buy-side insights, career advice, and more.
Our new tool lets you benchmark your IR program against peers in your region and sector, uncover strengths, and identify areas for growth.
Packed with industry trends and insights that define best-in-class practices across key, practical, and timely aspects of an IRO’s role.
Powered by the world’s largest survey of the buy side, sell side, and IR professionals, discover data-driven insights on running a successful IR program.